Detalhe da pesquisa
1.
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
Mult Scler
; 29(6): 648-656, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36440826
2.
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.
Mult Scler
; 28(5): 790-800, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382875
3.
Thoracic flexion provokes circumferential dysesthesia: A symptom of thoracic cord lesions in MS.
Mult Scler
; 27(7): 1008-1013, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552248
4.
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.
Mult Scler
; 27(14): 2170-2179, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783270
5.
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Mult Scler
; 27(14): 2219-2231, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769117
6.
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Mult Scler
; 25(6): 837-847, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761737
7.
Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Epilepsy Behav
; 80: 331-336, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433947
8.
Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.
Epilepsy Behav
; 31: 77-84, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24361767
9.
Novel biomarkers and interferon signature in secondary progressive multiple sclerosis.
J Neuroimmunol
; 389: 578328, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471284
10.
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
Neurol Ther
; 13(2): 283-322, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206453
11.
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Ophthalmology
; 120(7): 1432-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23531349
12.
Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models.
J Clin Invest
; 133(9)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115699
13.
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-ß-1a Compared to Non-PEGylated IFN-ß-1a.
J Interferon Cytokine Res
; 43(3): 108-120, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867172
14.
Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles.
Front Neurol
; 14: 1158487, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168665
15.
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study.
Mult Scler Relat Disord
; 74: 104718, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086634
16.
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles.
Front Neurol
; 14: 1245622, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614975
17.
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study.
Mult Scler Relat Disord
; 71: 104523, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773543
18.
Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(2)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535763
19.
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients.
Front Immunol
; 14: 1172993, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215103
20.
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.
Mult Scler Relat Disord
; 76: 104794, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356256